FDA hits Novartis with unexpected 3-month delay on MS drug ofatumumab

3rd June 2020 Uncategorised 0

FDA hits Novartis with unexpected 3-month delay on MS drug ofatumumab
arlene.weintraub
Wed, 06/03/2020 – 10:16




More: FDA hits Novartis with unexpected 3-month delay on MS drug ofatumumab
Source: fierce